Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2026-03-06 @ 10:27 AM
Study NCT ID:
NCT00713518
Status:
COMPLETED
Last Update Posted:
2012-10-12
First Post:
2008-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study).
Sponsor:
Quark Pharmaceuticals
Organization: